Drug lookup
Drug reference

Ferric carboxymaltose

Iron Supplement · Haematinic

Iron SupplementHaematinicATC B03AC
CDSCO approvedSchedule HATC B03AC
EXCRETION
not curated
INTERACTIONS
2 major
SEVERE in our sources
PREGNANCY
and used in the second or third
FDA category + note
Top interactions
  • DimercaprolSevereDatabaseDDInter
  • ErdafitinibSevereDatabaseDDInter

Mechanism

Ferric carboxymaltose is a colloidal iron preparation embedded within a carbohydrate polymer. It provides a source of iron for the synthesis of hemoglobin and replenishment of iron stores, particularly when oral iron therapy is unsuccessful due to intolerance, poor absorption, or ongoing blood loss.

Indications

Iron deficiency when oral therapy is unsuccessful (e.g., patient cannot tolerate oral iron, does not take it reliably, continuing blood loss, malabsorption)Management of chemotherapy-induced anaemia (when given with erythropoietins)Chronic renal failure patients (including those on haemodialysis or peritoneal dialysis) requiring intravenous ironAnaemia patients for rapid increase in haemoglobin level and replenishment of storesiron deficiency in heart failure (NYHA class II–III, hemoglobin levels of 9.5 to 13.5 g/dL)iron deficiency anemia in patients with intolerance to oral ironiron deficiency anemia in patients with unsatisfactory response to oral ironiron deficiency anemia in patients with non–dialysis-dependent chronic kidney diseaseIron deficiency anaemiaWhen oral iron is not toleratedFailure to absorb oral iron (malabsorption, inflammatory bowel disease, chronic inflammation)Non-compliance to oral ironSevere deficiency with chronic bleedingAlong with erythropoietin (to meet demands of induced rapid erythropoiesis)

Dosing

Adult
iron is given as a total dose or in divided doses. Further treatment should be guided by monitoring haemoglobin and serum iron concentrations.…
Pediatric
not recommended for children <14 years

Contraindications

  • Serious hypersensitivity reactions to intravenous iron, including life-threatening and fatal anaphylactic reactions
  • Iron overload (due to parenteral administration bypassing regulatory mechanisms)
  • i.m. injection

Side effects

Common
Pain at injection siteRashesHeadacheNauseaAbdominal painHypotension (infrequent)Flushing (infrequent)Chest pain (infrequent)dizzinessconstipationdiarrhearashinjection site reactions
Serious
  • Serious hypersensitivity reactions
  • Life-threatening and fatal anaphylactic reactions (rare)
  • anaphylaxis (rare)

Pregnancy & lactation

Pregnancy

and used in the second or third

Drug interactions

Dimercaprol
Severe
Database

Clinical effect not specified

Source: DDInter

Erdafitinib
Severe
Database

Clinical effect not specified

Source: DDInter

10 additional low-confidence interactions hidden — those rows lack a documented mechanism or management plan in our sources.

Related guidelines

Other Iron Supplement drugs

Ask House about Ferric carboxymaltose

Continue into a citation-backed clinical answer with the drug context already attached.

Sources: KD Tripathi 7e, Goodman & Gilman 14e, BNF·Verified: 2026-05-13 · House clinical team